| Trial ID: | L0160 |
| Source ID: | NCT02992548
|
| Associated Drug: |
Pravastatin
|
| Title: |
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Pravastatin
|
| Outcome Measures: |
Primary: mean change of erythrocyte membrane fatty acid including oleic acid, 24 weeks after intervention | Secondary: mean change of total cholesterol, 24 weeks after intervention|mean change of triglyceride, 24 weeks after intervention|mean change of LDL-cholesterol, 24 weeks after intervention|mean change of HDL-cholesterol, 24 weeks after intervention|mean change of adiponectin, 24 weeks after intervention
|
| Sponsor/Collaborators: |
Sponsor: Dong-A University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-09
|
| Completion Date: |
2018-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2019-03-11
|
| Locations: |
Dong-A University, Busan, 602715, Korea, Republic of|Inje University, Pusan Paik Hospital, Busan, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02992548
|
